This is a routine director-level sale tied to equity compensation vesting. No material signal for the stock. Monitor for any acceleration of insider selling patterns, but this filing alone does not warrant action.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · May 27 $25.48entry
- T+1 · 6mo ago +0.82%α +0.27% · $25.69
- T+5 · 6mo ago −1.41%α −2.62% · $25.12
- T+20 · 5mo ago +7.46%α +9.36% · $27.38
- T+60 · 3mo ago +1.88%α +0.00% · $25.96
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Director Kevin K. Gordon filed a Form 144 notice of intent to sell 5,500 shares of Progyny (PGNY) at an estimated aggregate market value of $137,445. The shares were acquired via restricted stock vesting on May 22, 2026, and the sale is for compensation-related purposes. This is a routine insider sale by a director, not an executive officer, and represents a small fraction of the company's $2.0B market cap.
Key Facts
- Director Kevin K. Gordon filed Form 144 to sell 5,500 shares of PGNY common stock.
- Estimated aggregate market value of the proposed sale is $137,445.
- Shares were acquired via restricted stock vesting on May 22, 2026.
- The sale is for compensation-related purposes, not a discretionary open-market sale.
- Gordon is a director, not an executive officer (CEO/CFO), reducing signaling weight.
- The proposed sale represents ~0.18% of the company's $2.0B market cap.
- No other insider sales or purchases in the prior 30 days were reported.
Financial Impact
Proposed sale of 5,500 shares worth ~$137,445, negligible relative to $2.0B market cap.
Risk Factors
- Form 144 is an intent to sell; the actual sale may not occur.
- Director sales carry less signaling weight than C-suite sales.
- No other insider activity to corroborate a bearish thesis.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001959173-26-004031 |
| Document: 0001959173-26-004031-index.html | 0001959173-26-004031 |
| Document: 0001959173-26-004031.txt | 0001959173-26-004031 |
Track record
26 reports on PGNY
3 of 3 bullish or bearish reports moved the stock their way by T+5. Best: +6.43% at T+5 after the Nov 4, 2026 report. 3 of 4 went positive at some point.
Filters
- Nov 13, 20263d ago Insider Cluster Neutral 2/10 Entry $36.75 Now $37.15 +1.09% settles Nov 23
- Nov 12, 20264d ago Insider Cluster Bearish 4/10 Entry $36.18 Now $37.15 −2.68% settles Nov 20
- Nov 12, 20264d ago 144 Neutral 2/10 Entry $36.58 Now $37.15 +1.56% settles Nov 19
- Nov 10, 20266d ago 144 Neutral 3/10 Entry $36.50 Now $37.15 +1.78% settles Nov 18
- Nov 9, 20267d ago Insider Cluster Neutral 2/10 Entry $36.43 Now $37.15 +1.98% settles Nov 17
- Nov 5, 202611d ago 144 Neutral 3/10 Entry $34.84 to $36.18 Now $37.15 +6.63% ▲ +3.85% +1.25% vs SPY
- Nov 5, 202611d ago 144 Neutral 2/10 Entry $34.84 to $36.18 Now $37.15 +6.63% ▲ +3.85% +1.25% vs SPY
- Nov 5, 202611d ago 144 Neutral 3/10 Entry $34.84 to $36.18 Now $37.15 +6.63% ▲ +3.85% +1.25% vs SPY
- Nov 4, 202612d ago 8-K Bullish 6/10 No price data
- Nov 4, 202612d ago Press Release Bullish 6/10 Entry $34.37 to $36.58 Now $37.15 +8.09% ▲ +6.43% +3.14% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers